Memphis Co. for Pharmaceutical & Chemical Industries posted financial statements for the fiscal year that ended on June 30, 2014, mirroring EGP 14.025 thousand net profit after tax, with a drop by 99.7% compared with EGP 5.2 million in FY12/13.
The drug manufacturer had reported EGP 1 million net loss before tax for the 11-month period from July 1, 2013 till May 31, 2014, against EGP 3.5 million net profit in the year-ago period.